Good to Know > Dasacine, a Chemo Drug that targets Blood Cancer.

Dasacine, a Chemo Drug that targets Blood Cancer.

Comprising Dasatinib, it is a targeted therapy drug for CML and ALL

Arechar Healthcare, one of the foremost life-saving drug manufacturers, is all set for the launch of Dasatinib, under the brand name Dasacine, which is expected to be the best solution for the easy treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). It has been evident that the risk of developing cancer is increasing with the ignorance of healthcare among the people. Even after the diagnosis, the patients aren’t able to get the right and timely treatment. To increase accessibility, Arechar Healthcare has come up with such life-saving drugs and has prioritized the most serious sector of treatment.

“With the launch of Dasacine, I feel happy to manifest my contribution to the healthcare sector, specifically oncology, for I know the value of the human lives being disturbed by cancer and tumors,” said Harpreet Singh, Founder of Arechar Healthcare. “Dasacine is an orally bioavailable synthetic small molecule-inhibitor, which is a multi-targeted kinase inhibitor that can act as an essential element in the treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL), with the highest efficacy.”

“With the increasing incidence of cancer in our world, we strive to bestow the best life-saving drugs, keeping in mind the accessibility and affordability of the medicines we offer. Humanity comes from actions based on our beliefs, therefore we execute the humanitarian beliefs with such steps towards healthcare, specifically in the field of oncology,” he added.

Dasatinib is a targeted therapy. It is used in the treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). The molecular weight of Dasatinib is 488 g/mol. It is a tyrosine-kinase inhibitor. Its molecular formula is C22H26ClN7O2S.

Dasacine is a  prescription medicine used in the treatment of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). It is available in the strength of 50 mg and 70 mg.

About Arechar Healthcare

Arechar Healthcare is one of the largest leading manufacturers of life-saving drugs, working to serve the patients with the best and approved life-saving drugs at an affordable range of prices. It has attained an authoritative position worldwide in the field of Pharma. It has successfully extended its reach globally and is working with immense insight into humanity. Very few manufacturers possess the drive and determination that the Arechar Healthcare Team has displayed, ever since it started. Focussing on the accessibility and efficacy of life-saving drugs, Arechar Healthcare aims to strengthen the healing and treatment process, with a major focus on oncology care and other diseases that threaten human lives.